TheraRadar
Clinical-Stage Companies / Catalysis SL

Catalysis SL

Pre-Approval PRO BETA
45
Total Trials
24
Phase 3
23
Phase 2
1
Recruiting
549
Score

Pipeline by Phase

Phase 3
24
Phase 2
23
Phase 1

Therapeutic Focus

Gastrointestinal Neoplasms Digestive System Neoplasm Gastrointestinal Disease Digestive System Disease Endocrine System Diseases

Clinical Trials (45)

NCT06361992 Phase 3 COMPLETED

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

Started: 3/15/2022

NCT03541005 Phase 3 COMPLETED

Evaluation of Obex® in Overweight and Obesity

Started: 10/1/2018

NCT01099319 Phase 3 COMPLETED

Renalof in the Treatment of Elderly Patients With Gallstones

Started: 1/1/2010

NCT01111344 Phase 3 COMPLETED

Glizigen-Viudid-External Anogenital Warts in Children and Adolescents

Started: 12/1/2010

NCT01001624 Phase 3 COMPLETED

Melanil in the Treatment of Melasma

Started: 10/1/2009

NCT01016470 Phase 3 COMPLETED

Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease

Started: 10/1/2009

NCT01051024 Phase 3 COMPLETED

Diamel in the Treatment of Polycystic Ovary Syndrome

Started: 11/1/2009

NCT00778843 Phase 3 COMPLETED

Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C

Started: 10/1/2008

NCT00967681 Phase 3 COMPLETED

Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

Started: 9/1/2009

NCT00820651 Phase 3 COMPLETED

Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis

Started: 11/1/2009

NCT00969527 Phase 3 COMPLETED

Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis

Started: 9/1/2009

NCT00994266 Phase 3 COMPLETED

Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy

Started: 10/1/2009

NCT01043367 Phase 3 COMPLETED

Deprexil in Subjects With Signs and Symptoms of Depression

Started: 1/1/2010

NCT00975117 Phase 3 COMPLETED

Spermotrend in the Treatment of Male Infertility

Started: 9/1/2009

NCT00993005 Phase 3 COMPLETED

CICATRIX in the Treatment of Hypertrophic Scars and Keloids Scars

Started: 10/1/2009

NCT00991367 Phase 3 COMPLETED

CICATRIX in the Treatment of Recent Post-surgical Scars

Started: 10/1/2009

NCT00978224 Phase 3 SUSPENDED

Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment

Started: 10/1/2009

NCT00978887 Phase 3 COMPLETED

Retorna Facial Cream in the Treatment of Facial Wrinkles

Started: 10/1/2009

NCT01025115 Phase 3 COMPLETED

Diamel in the Treatment of Metabolic Syndrome

Started: 3/1/2009

NCT01016119 Phase 3 COMPLETED

Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke

Started: 10/1/2009

NCT01022060 Phase 3 COMPLETED

Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis

Started: 11/1/2009

NCT07179237 Phase 2 RECRUITING

Efficacy of Carminal in Helicobacter Pylori Gastritis

Started: 8/4/2025

NCT03559543 Phase 2 COMPLETED

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

Started: 10/25/2018

NCT03549494 Phase 2 COMPLETED

Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction

Started: 10/25/2018

NCT03717298 Phase 2 COMPLETED

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Started: 10/30/2018

NCT05222841 Phase 2 COMPLETED

The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility

Started: 6/15/2021

NCT03562897 Phase 2 COMPLETED

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Started: 10/25/2018

NCT04701502 Phase 2 COMPLETED

Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19

Started: 11/9/2020

NCT04407182 Phase 2 COMPLETED

Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19

Started: 5/4/2020

NCT04695951 Phase 2 COMPLETED

Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract

Started: 8/1/2019

NCT03540407 Phase 2 COMPLETED

Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Started: 1/7/2015

NCT03533478 Phase 2 COMPLETED

Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema

Started: 3/1/2015

NCT03543670 Phase 2 COMPLETED

Evaluation of Oncoxin-Viusid® in Prostate Cancer

Started: 9/16/2017

NCT03584308 Phase 2 COMPLETED

Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal

Started: 10/15/2015

NCT03577535 Phase 2 COMPLETED

Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

Started: 11/1/2017

NCT03583593 Phase 2 COMPLETED

Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer

Started: 5/23/2014

NCT03576521 Phase 2 COMPLETED

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Started: 5/13/2015

NCT03541772 Phase 2 COMPLETED

Evaluation of Oncoxin-Viusid® in Head and Neck Cancer

Started: 1/20/2015

NCT03541148 Phase 2 COMPLETED

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Started: 9/16/2014

NCT02145442 Phase 2 COMPLETED

Effects of Obex in Overweight and Obese Patients

Started: 6/1/2014

NCT01934036 Phase 2 COMPLETED

Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women

Started: 8/1/2013

NCT01018212 Phase 2 COMPLETED

Cicatrix Cream in Cutaneous Groves

Started: 9/1/2009

NCT01018589 Phase 2 COMPLETED

Cicatrix Cream in Post Surgical Scars and Epidermic Burn

Started: 9/1/2009

NCT01008007 Phase 2 COMPLETED

Viusid in Adults With Acute Fever of Viral Etiology

Started: 9/1/2009

NCT03550482 Phase 4 COMPLETED

Oncoxin® and Quality of Life in Cancer Patients

Started: 11/1/2017

Drug Candidates

Standard Care Placebo Conventional treatment Folrex
Activity Status: Active
Last Trial Started: 8/4/2025
Last Trial Ended: 2/13/2024
Trials (12 months): 1
Completed Trials: 43
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.